Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
World Journal of Urology
Published October 1, 2026
Surrogacy of intermediate clinical endpoints for overall survival in BCG-naïve high-risk non-musc...
October 2, 2026
Medspoke
Medspoke
Clinical Cancer Research
Published October 1, 2026
00:00
--:--
FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Foll...
October 2, 2026
Share
FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma.
https://www.medspoke.co/channel_journal?id=686&tap_id=14931
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Cancer Discovery
Published October 1, 2026
Genomic alterations and treatment define spatiotemporal patterns of glioblastoma recurrence.
October 2, 2026
Why are you reporting this TALK?
